These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


311 related items for PubMed ID: 10330296

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
    Garcia G, Komagata Y, Slavin AJ, Maron R, Weiner HL.
    J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.
    Daniel D, Gill RG, Schloot N, Wegmann D.
    Eur J Immunol; 1995 Apr; 25(4):1056-62. PubMed ID: 7537670
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y, Hara-Yakoyama C, Guadiz AA, Udaka S, Kiyono H, Chatterjee S.
    Biotechnol Bioeng; 2005 Dec 30; 92(7):803-9. PubMed ID: 16142801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY, Singh B.
    J Autoimmun; 1997 Jun 30; 10(3):271-8. PubMed ID: 9218754
    [Abstract] [Full Text] [Related]

  • 12. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ.
    Diabetes; 2007 Aug 30; 56(8):2116-23. PubMed ID: 17496235
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor-1 (IGF-1)-derived peptide protects against diabetes in NOD mice.
    Kodama K, Shimada A, Funae O, Morimoto J, Irie J, Shigihara T, Oikawa Y, Tokui M, Watanabe K, Saruta T.
    Autoimmunity; 2004 Aug 30; 37(6-7):481-7. PubMed ID: 15621575
    [Abstract] [Full Text] [Related]

  • 16. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
    Sévère S, Gauvrit A, Vu AT, Bach JM.
    Mol Immunol; 2007 Apr 30; 44(11):2950-60. PubMed ID: 17336387
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
    Li AF, Hough J, Henderson D, Escher A.
    Vaccine; 2004 Apr 16; 22(13-14):1751-63. PubMed ID: 15068859
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation.
    Murray JS, Oney S, Page JE, Kratochvil-Stava A, Hu Y, Makagiansar IT, Brown JC, Kobayashi N, Siahaan TJ.
    Chem Biol Drug Des; 2007 Sep 16; 70(3):227-36. PubMed ID: 17718717
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.